The FDA recently gained more leverage over pharmaceutical companies. Will it use it?

📆 2023-02-26 오전 12:57:00
📰 NPRHealth

⏱ Reading Time:
1 sec. here
2 min. at publisher
📊 Quality Score:
News: 4%
Publisher: 63%

대한민국 뉴스 뉴스

대한민국 최근 뉴스,대한민국 헤드 라인

The U.S. Food and Drug Administration late last year got more leverage over pharmaceutical companies that received accelerated approvals for their drugs. How will the agency use its new powers?

이 소식을 빠르게 읽을 수 있도록 요약했습니다. 뉴스에 관심이 있으시면 여기에서 전문을 읽으실 수 있습니다. 더 많은 것을 읽으십시오:

댓글 쓰기

Not under the Biden administration.

Worked on TecentriqHCP startup in NSCLC for North America while at PPDCRO at the end of 2014. US_FDA approved it by 2019. Wrote so many reports for GO29436, 437, 537, 432, 431, 527 got RSI. PPD wrongfully terminated me 2017 after they injured fly_BUR in 2016. You’re welcome

대한민국 최근 뉴스, 대한민국 헤드 라인